GlassScriptPhysician profile
Sarah E Newman
NPI 1578590139
$968.88
in general payments reported to CMS, 2019-2025
17 companies · $59.89 in 2025
The $59.89 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $130 · 2021: $85.66 · 2022: $186 · 2023: $234 · 2024: $63.95 · 2025: $59.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.35 | 2019-2023 | |
| Astellas Pharma US INC | $118.82 | 2022-2023 | Veozah |
| Mayne Pharma Commercial LLC | $69.55 | 2023-2025 | |
| Exeltis, USA INC. | $43.19 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $42.84 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Medtronic, INC. | $42.43 | 2023-2024 | Truclear, Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $41.58 | 2019-2021 | |
| Organon LLC | $40.71 | 2021-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $33.01 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $32.40 | 2022 | |
| Amag Pharmaceuticals, INC. | $27.58 | 2019-2020 | |
| Allergan, INC. | $24.99 | 2019 | |
| Biogen, INC. | $23.35 | 2024 | |
| Agile Therapeutics, INC. | $14.97 | 2021 | |
| Pfizer INC. | $14.59 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $13.80 | 2022 | |
| Amgen INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.